Syra Health (SYRA) Proxy filing summary

Executive summary

• Annual meeting scheduled for July 23, 2026, to elect five directors, ratify the auditor, and amend the equity incentive plan.

• Record date for voting is May 28, 2026; both Class A and Class B shareholders are eligible to vote.

• Proxy materials are available online, and shareholders can vote by internet, mail, or in person.

Voting matters and shareholder proposals

• Shareholders will vote on: (1) election of five directors, (2) ratification of M&K CPAS, PLLC as auditor for 2026, (3) amendment to increase shares in the 2022 Omnibus Equity Incentive Plan to 4,100,000.

• Board recommends voting “FOR” all proposals.

• Shareholder proposals for the 2027 meeting must be submitted between March 26 and April 25, 2027.

Board of directors and corporate governance

• Board consists of five nominees, with three deemed independent under Nasdaq rules.

• Committees: Audit, Compensation, and Nominating & Governance, all with independent members.

• Board meets quarterly; independent directors meet separately.

• Code of Business Conduct and Ethics in place; insider trading and anti-hedging policies enforced.

• No family relationships among directors and officers.